September 20, 2025PLoS ONEOpen Access

Development and validation of a machine learning-based predictive model for clinical remission in Crohn’s disease patients receiving Adalimumab therapy

View Full Paper

Ask AI

Bookmark

Authors

PXPianpian XiaCentral South University FDFeihong Deng DLDeliang LiuWeifang Medical University

Discussion

Member takes

Implication

Retrospective study develops a machine learning model predicting remission in Crohn’s disease patients, suggesting key biomarkers like fecal calprotectin significantly influence outcomes.

Key Points

The study developed a machine learning model to predict clinical remission in Crohn's disease patients, enhancing treatment personalization.
Model performance showed that XGBoost outperformed other algorithms, achieving high accuracy and sensitivity with significant predictive power.
Key biomarkers such as fecal calprotectin and C-reactive protein were identified, reflecting individual variability in patient responses to adalimumab therapy.
Future research should involve multi-center collaboration and integrate multi-omics data, broadening the model’s ability to uncover disease mechanisms.

Cite This Study

Xia et al. (2025) studied this question.

synapsesocial.com/papers/68d46fcd31b076d99fa69f48 https://doi.org/10.1371/journal.pone.0331447

View Full Paper

Ask AI

Bookmark

Implication

Retrospective study develops a machine learning model predicting remission in Crohn’s disease patients, suggesting key biomarkers like fecal calprotectin significantly influence outcomes.

Development and validation of a machine learning-based predictive model for clinical remission in Crohn’s disease patients receiving Adalimumab therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Development and validation of a machine learning-based predictive model for clinical remission in Crohn’s disease patients receiving Adalimumab therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider